A Clinical Study Evaluating H1710 for Injection in Participants With Advanced Solid Tumors

Clinical trial NCT06992713 · RECRUITING

Trial details

NCT number: NCT06992713
Sponsor: Shenzhen Hepalink Pharmaceutical Group Co., Ltd.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Solid Tumor

Start date: 2025-06-18
Primary completion: 2026-09-04
Enrollment: 36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.